A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation

Radiotherapy and Oncology

Volumn 113, Issue 1, 2014, Pages 84-88

  Zhang, Rui ^a,b   Howell, Rebecca M ^a,b   Taddei, Phillip J ^a,b,c   Giebeler, Annelise ^a,b,e   Mahajan, Anita ^b   Newhauser, Wayne D ^a,b,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e Scripps Proton Therapy Center   (United States)

Author keywords

Cardiac mortality; Craniospinal irradiation; Medulloblastoma; Proton therapy; Second cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTRIBUTABLE RISK; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CARDIOVASCULAR MORTALITY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRANIOSPINAL IRRADIATION; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MEDULLOBLASTOMA; PHOTON THERAPY; PRESCRIPTION; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RISK FACTOR; SECOND CANCER; TREATMENT PLANNING; ADVERSE EFFECTS; CEREBELLAR NEOPLASMS; HEART DISEASES; IONIZING RADIATION; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PHOTON; PRESCHOOL CHILD; PROCEDURES; THERAPEUTIC USE; YOUNG ADULT;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIOSPINAL IRRADIATION; FEMALE; HEART DISEASES; HUMANS; MALE; MEDULLOBLASTOMA; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PHOTONS; PROTON THERAPY; RADIATION DOSAGE; RADIATION, IONIZING; RISK FACTORS; YOUNG ADULT;

EID: 84922719619     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.07.003     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Hewitt M, Weiner SL, Simone JVE. Childhood cancer survivorship: improving care and quality of life. Washington (DC): National Academies Press; 2003.
3. Fossati P, Ricardi U, Orecchia R. Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev 2009; 35: 79-96.
4. NCRP. Report No. 170: second primary cancers and cardiovascular disease after radiation therapy; 2011.
5. Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol 2012; 30: 3734-45.
6. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 2009; 91: 4- 15; discussion 11-13.
7. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27: 2328-38.
8. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-82.
9. Lipshultz SE, Adams MJ. Cardiotoxicity after childhood cancer: beginning with the end in mind. J Clin Oncol 2010; 28: 1276-81.
10. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339: b4606.
11. Newhauser WD, Fontenot JD, Mahajan A, et al. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 2009; 54: 2277-91.
12. Mu X, Bjoerk-Eriksson T, Nill S, et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol 2005; 44: 554-62.
13. Brodin NP, Rosenschold PM, Aznar MC, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 2011; 50: 806-16.
14. Zhang R, Howell RM, Giebeler A, Taddei PJ, Mahajan A, Newhauser WD. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol 2013; 58: 807-23.
15. Taddei PJ, Mahajan A, Mirkovic D, et al. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol 2010; 55: 7067-80.
16. Howell RM, Giebeler A, Koontz-Raisig W, et al. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 2012; 7: 116-27.
17. Giebeler A, Newhauser WD, Amos RA, Mahajan A, Homann K, Howell RM. Standardized treatment planning methodology for passively scattered proton craniospinal irradiation. Radiat Oncol 2013; 8: 32.
18. ICRU. Prescribing, recording, and reporting proton-beam therapy ICRU Report 78; 2007.
19. NRC. Health risks from exposure to low levels of ionizing radiation: BEIR VII - phase 2. Nation research council of the national academies; 2006.
20. Perez-Andujar A, Newhauser WD, Taddei PJ, Mahajan A, Howell RM. The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation. Phys Med Biol 2013; 58: 3107-23.
21. Hendricks JS, McKinney GW, Durkee JW, et al., MCNPX, version 26c; 2006.
22. Taddei PJ, Jalbout W, Howell RM, et al. Analytical model for out-of-field dose in photon craniospinal irradiation. Phys Med Biol 2013; 58: 7463-79.
23. Howell RM, Scarboro SB, Taddei PJ, Krishnan S, Kry SF, Newhauser WD. Methodology for determining doses to in-field, out-of-field and partially infield organs for late effects studies in photon radiotherapy. Phys Med Biol 2010; 55: 7009-23.
24. Howell RM, Scarboro SB, Kry SF, Yaldo DZ. Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol 2010; 55: 6999-7008.
25. Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010; 28: 1308-15.
26. CBTRUS. Statistical report: primary brain tumors in the United States, 2004- 2008; 2012.
27. Packer RJ, Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol 2008; 65: 1419-24.
28. Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ. A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Radiat Environ Biophys 2009; 48: 263-74.
29. Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ. A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys 2009; 48: 275-86.
30. Schneider U, Sumila M, Robotka J. Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theoret Biol Med Model 2011; 8: 27.
31. Schneider U, Sumila M, Robotka J, Gruber G, Mack A, Besserer J. Dose-response relationship for breast cancer induction at radiotherapy dose. Radiat Oncol 2011; 6: 67.
32. Paganetti H, Athar BS, Moteabbed M, Adams JA, Schneider U, Yock TI. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Phys Med Biol 2012; 57: 6047-61.
33. Hillbrand M, Georg D, Gadner H, Potter R, Dieckmann K. Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol 2008; 89: 141-9.
34. Sharma DS, Gupta T, Jalali R, Master Z, Phurailatpam RD, Sarin R. Highprecision radiotherapy for craniospinal irradiation: evaluation of threedimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy. Br J Radiol 2009; 82: 1000-9.
35. Mesbah L, Matute R, Usychkin S, et al. Helical tomotherapy in the treatment of pediatric malignancies: a preliminary report of feasibility and acute toxicity. Radiat Oncol 2011; 6: 102.
36. Fogliata A, Bergstrom S, Cafaro I, et al. Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-institutional treatment experience. Radiother Oncol 2011; 99: 79-85.
37. Zhang R, Howell RM, Homann K, et al. Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy. Radiat Oncol 2013; 8: 184.